OlmeTine Tablet 20/20 mg

Adult dose

Olmesartan Medoxomil: The recommended initial dose is 10 mg once daily, administered irrespective of meals. If blood pressure is not adequately controlled, the dosage can be increased to 20 mg once daily, with a maximum of 40 mg per day. Rosuvastatin: The initial dose is 5 mg once daily, with a maintenance dose of 10 mg once daily. The dosage may be increased to a maximum of 20 mg once daily.

Child dose

The safety and efficacy in pediatric patients under 18 years of age have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with hypersensitivity to this medication, in pregnant or breastfeeding women, or in fertile women who are not using adequate contraception. This medication should not be administered to patients with certain health conditions such as severely impaired renal function or those undergoing dialysis, severe liver impairment, cholestasis, or myopathy. Hypotension may occur in patients with low blood volume or salt deficiency, so sufficient precursory checks and caution are necessary before administration, and regular monitoring is needed due to the potential for kidney function changes. Myalgias, myopathy, and, rarely, rhabdomyolysis may occur, so immediate medical attention is required if muscle-related symptoms occur. Liver function abnormalities have also been reported, and periodic liver enzyme testing is necessary; if signs of liver damage appear, administration should be stopped immediately. This medication can lower blood pressure, which may cause dizziness; caution should be used when driving or operating dangerous machinery. Drug interactions may occur with certain medications, so patients taking other drugs should inform their healthcare providers, especially with potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs. Women who are pregnant or could become pregnant must use adequate contraception and should not use this medication during pregnancy. The safety and efficacy of this medication have not been established in children under 18 years old, so use is not recommended. In the elderly, dosing adjustments and monitoring may be necessary due to potential increases in drug concentration. Overdosage can lead to symptoms such as hypotension and palpitations; immediate medical treatment should be sought in such cases. This medication should be kept out of reach of children, and should not be transferred to other containers.

Serious side effects

Urticaria, severe swelling (angioedema), anaphylaxis, chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, mucosal pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities associated with cough and fever, jaundice (yellowing of the skin or eyes), profound malaise, sudden and severe headache, thunderclap headache, seizure, altered consciousness, visual disturbances

Mild side effects

• Headache
• dizziness
• sensory disturbances
• drowsiness
• gastroesophageal reflux disease
• constipation
• dental caries
• dyspepsia
• gastric ulcer
• gastritis

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best kept at room temperature, between 1°C and 30°C, to maintain the medication's efficacy over time.

Appearance

White or yellowish round film-coated tablets

Package unit

30 tablets/box [30 tablets (10 tablets/Alu-Alu) x 3]